Dr. Arturo Chayet
Dear Friends, I would like to tell you a little bit about myself in order to help make your decision on this important topic a little easier.
From the very beginning of my medical training, the wonders that are possible in Refractive Surgery allowed me to develop a passion for my line of work. I began doing refractive surgery as a second year Resident at the Instituto de Oftalmologia in Mexico City in August 1985. I was amazed by the impact a simple surgical procedure could have on people's lives.
Consequently, in order to bolster my surgical skills and knowledge, I decided to do a Fellowship in Cornea and Refractive Surgery at the prestigious UC San Diego Department of Ophthalmology in 1987. Here, my affinity for the subspecialty of Refractive Surgery only grew larger and I decided not only to incorporate it into my main clinical practice, but I became very enthusiastic in finding ways to improve results. I participated in several studies for Radial Keratotoy (RK), thermokeratoplasty (TK) and astigmatic keratotomy (AK). In 1994, we introduced the excimer laser to our practice.
At the time, Photorefractive Keratectomy (PRK) was the procedure conducted with excimer laser, but at the same time another procedure called Automated Keratomileusis (ALK) was also being utilized in different parts of the world. With PRK, a very precise amount of cornea tissue is removed in order to create the refractive correction in the eye. With ALK, a flap is made with a steel-blade, call the microkeratome, which is subsequently followed with a second pass using the same instrument to create the refractive correction. PRK had the advantage of precision, but the disadvantage of prolonged healing, while ALK had the advantage of immediate healing but the disadvantage of lacking precision. Eventually, however, many surgeons around the world, including Dr. Pallikaris in Greece (1990), realized that synergizing the best qualities of both PRK and ALK could yield a procedure that was both precise and yielded expeditious healing, namely what would be known as LASIK.
From the beginning of my excimer laser era, I knew LASIK was the way to go in laser vision correction and as early as June of 1994 I did my first LASIK procedure, which turned to be the very first LASIK procedure in the Western part of North America. Since then, I have done over 40,000 procedures, taught LASIK to thousands of eye surgeon around the world and have published dozens of articles on LASIK in the most prestigious scientific journals.
The first breakthrough discovery of my career took place in 1995. At the time, my position on LASIK was that the excimer laser was extremely accurate, but that the microkeratome technique of flap making could be drastically improved with the use of a laser. I made this very recommendation to a small start-up. After initial studies using the Picosecond Laser to create a flap, we had begun to develop a technology which would come to revolutionize the way in which laser vision correction is delivered to the patient. The idea know as Intralasik or ALL-Laser LASIK was born. In 2001, using a new Femtosecond laser, we began the initial studies of custom flaps, a technique which is today considered to be the premier procedure in refractive surgery.
My second breakthrough discovery took place in 1997 when I invented Bitoric LASIK for the correction of the most complex cases of astigmatism (Mixed Astigmatism). Bitoric LASIK has since been the universal procedure of choice when dealing with the most complex refractive errors. With the Bitoric formula, now many more patients became great candidates for LASIK, not just people with standard refractive errors.
In 2000, in light of these accomplishments and many more, the International Society of Refractive Surgery awarded me with the Lans Lecture Award. It has been the utmost honor to be recognized in the field of refractive surgery by my peers around the world.
Understanding the importance of vision in each individual’s life, I have taken the business of refractive surgery very seriously. Proper patient selection with the use of the most sophisticated available diagnostic equipment along with my 24 years refractive surgery expertise allows me to ensure maximum safety; in addition, proper technology selection, such as the uses of the best excimer and femtosecond lasers, along with my vast experience of thousands of cases, allows me to provide the patient with maximum amount of efficacy. Safety and efficacy are the key elements when choosing a refractive procedure and refractive surgeon.
I love to meet and talk with my patients, not only about the refractive procedure, but also about their lives, their expectations and their needs. I always look forward to meet new people and to help them achieve their dreams.
Dr. Arturo Chayet
Dr. Arturo Chayet is widely considered to be a pioneer in both Cataract and IOL surgery and investigations. He has performed over 10,000 Cataract cases including the most complex cases of anterior segment and IOL surgery reconstruction.
Dr. Chayet is considered one of the most skillful Cataract surgeons who enjoys working in a very modern surgical environment, in which the most advanced techniques in diagnostics and therapeutics are employed. He utilizes microincision, advanced ultrasonic cataract surgery with a wide range of IOLs. Dr. Chayet takes pride in fully customizing each and every IOL implantation, in which the type of surgical technique and IOL selection chosen is strategically selected to perfectly fit the individual’s needs, which are based on a comprehensive, preoperative one-on-one consultation with Dr. Chayet. His ultimate goal after each and every IOL implantation is to deliver the maximum amount of rejuvenated natural vision.
Not only a pioneer in surgery but also in clinical investigations, the world’s most advanced and innovative IOL technologies are brought to CODET so that Dr. Chayet can help develop them at the clinical level. In 1999, Dr. Chayet conducted the first clinical trial on accommodating IOLs for Ionics (now Bausch & Lomb). He was instrumental in the development of the Crystalens; the first FDA approved accommodating IOL. Additionally, since 2003, Dr. Chayet has been working with world-class scientists, such as Dr. Dan Schwartz (UCSF) and 2005 Nobel Prize Winner Dr. Robert Grubs (Cal Tech), in the development of the most advanced and state of the art technology in IOLs, namely the Calhoun Vision Light Adjustable Lens (LAL).